Citizens Financial Group’s AstraZeneca AZN Stock Holding History

Citizens Financial Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-283	Closed	-$30K	–	305
2020 Q2	$30K	Hold	283	–	–	﹤0.01%	559
2020 Q1	$25K	Hold	283	–	–	﹤0.01%	558
2019 Q4	$28K	Sell	283 -94	-25%	-$8.85K	﹤0.01%	550
2019 Q3	$33K	Sell	377 -4	-1%	-$347	﹤0.01%	412
2019 Q2	$31K	Buy	381 +95	+33%	+$7.45K	﹤0.01%	405
2019 Q1	$23K	Buy	+286	New	+$22.5K	﹤0.01%	425
2017 Q3	–	Sell	-49	Closed	-$3K	–	510
2017 Q2	$3K	Sell	49 -251	-84%	-$16.4K	﹤0.01%	484
2017 Q1	$19K	Sell	300 -9	-3%	-$524	﹤0.01%	394
2016 Q4	$17K	Buy	+309	New	+$17.5K	﹤0.01%	416

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Citizens Financial Group's AZN Position: Q3 2020 in Review

Citizens Financial Group sold out of AstraZeneca (AZN) in Q3 2020, closing a stake of 283 shares — an estimated $30K sold.

Citizens Financial Group first reported a position in AZN in Q4 2016 and held it in 9 quarters. The position peaked at $33K in Q3 2019. 723 funds tracked by Wall St. Rank hold AZN as of Q3 2020.

Citizens Financial Group reported no remaining AstraZeneca position as of Q3 2020 after selling out during the quarter.
Citizens Financial Group sold 283 AstraZeneca shares in Q3 2020, an estimated $30K.
Citizens Financial Group first reported a position in AstraZeneca in Q4 2016 and held it in 9 quarters.
Citizens Financial Group's AstraZeneca position peaked at $33K in Q3 2019.
723 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2020.

Based on Citizens Financial Group's 13F filing for Q3 2020, filed 12 Nov 2020.